CS logo
small CS logo
University of Nebraska

Omaha, Nebraska, United States
Public university in Omaha, Nebraska
6001 Dodge St, Omaha, NE 68182

About University of Nebraska


The University of Nebraska Omaha is a public research university in Omaha, Nebraska. Founded in 1908 by faculty from the Omaha Presbyterian Theological Seminary as a private non-sectarian college, the university was originally known as the University of Omaha.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Nebraska
21
Celgene
4
Cephalon
4
Chimerix
4
CF Therapeutics Development Network Coordinating Center
2
Celgene Corporation
2
Kite, A Gilead Company
2
Kosin University
2
Sanofi
2
Seagen Inc.
2
Shire
2
Total Rows: 62

Clinical Trials at University of Nebraska


During the past decade, University of Nebraska conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 17 clinical trials were completed, i.e. on average, 31.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 8 clinical trials were completed. i.e. 38.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years6655441010881212226611222200223322441111Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Galantamine in the Treatment of Alzheimer's Disease
Completed
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
2002-05-01
2003-05-01
Completed
354
A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies
2003-08-01
Completed
70
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
2002-06-01
2004-03-01
Completed
72
Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients
2003-05-01
Terminated
420
Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
2003-06-01
2005-10-01
Terminated
100
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
2003-10-01
2010-01-01
Completed
224
Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
2004-02-01
2006-12-01
Completed
80

Rows per page:

1–98 of 98

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Nebraska" #1 sponsor was "University of Nebraska" with 21 trials, followed by "Celgene" with 4 trials sponsored, "Cephalon" with 4 trials sponsored, "Chimerix" with 4 trials sponsored and "CF Therapeutics Development Network Coordinating Center" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 62 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nebraska" #1 collaborator was "Cystic Fibrosis Foundation" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "University of Nebraska" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Blood and Marrow Transplant Clinical Trials Network" with 2 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 81 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Nebraska: 21University of Nebraska: 21Celgene: 4Celgene: 4Cephalon: 4Cephalon: 4Chimerix: 4Chimerix: 4CF TherapeuticsDevelopment NetworkCoordinating Center: 2CF TherapeuticsDevelopment NetworkCoordinating Center: 2Celgene Corporation: 2Celgene Corporation: 2Kite, A Gilead Company: 2Kite, A Gilead Company: 2Kosin University: 2Kosin University: 2Sanofi: 2Sanofi: 2Seagen Inc.: 2Seagen Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsCystic Fibrosis Foundation: 4Cystic Fibrosis Foundation: 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4University of Nebraska: 4University of Nebraska: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Blood and MarrowTransplant Clinical TrialsNetwork: 2Blood and MarrowTransplant Clinical TrialsNetwork: 2National Cancer Institute (NCI): 2National Cancer Institute (NCI): 2National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 2National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 2National Institute ofNeurological Disordersand Stroke (NINDS): 2National Institute ofNeurological Disordersand Stroke (NINDS): 2Oregon Health andScience University: 2Oregon Health andScience University: 2Pfizer: 2Pfizer: 2

Clinical Trials Conditions at University of Nebraska


According to Clinical.Site data, the most researched conditions in "University of Nebraska" are "Cystic Fibrosis" (5 trials), "Peripheral Arterial Disease" (5 trials), "Parkinson Disease" (3 trials), "Stroke" (3 trials) and "ADHD" (2 trials). Many other conditions were trialed in "University of Nebraska" in a lesser frequency.

Clinical Trials Intervention Types at University of Nebraska


Most popular intervention types in "University of Nebraska" are "Drug" (55 trials), "Device" (13 trials), "Other" (13 trials), "Biological" (10 trials) and "Dietary Supplement" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Brincidofovir" (3 trials), "Exercise" (3 trials), "Modafinil" (3 trials) and "3D Printed Upper-limb Prosthesis" (2 trials). Other intervention names were less common.

Clinical Trials Genders at University of Nebraska


The vast majority of trials in "University of Nebraska" are 92 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at University of Nebraska


Currently, there are 21 active trials in "University of Nebraska". 1 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 52 completed trials in University of Nebraska, 1 suspended trials, and 16 terminated clinical trials to date.
Out of the total trials that were conducted in University of Nebraska, 6 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 24 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 26Phase 2: 26Not Applicable: 24Not Applicable: 24Phase 3: 22Phase 3: 22Phase 4: 9Phase 4: 9Phase 1: 6Phase 1: 6

Created with Highcharts 11.1.0Trials StatusCompleted: 52Completed: 52Terminated: 16Terminated: 16Recruiting: 10Recruiting: 10Active, not recruiting: 8Active, not recruiting: 8Withdrawn: 4Withdrawn: 4Unknown status: 3Unknown status: 3Enrolling by invitation: 2Enrolling by invitation: 2No longer available: 1No longer available: 1Not yet recruiting: 1Not yet recruiting: 1Suspended: 1Suspended: 1

Departments of University of Nebraska


University of Nebraska has several departments that took part in Clinical trials: "Division of Physical Therapy Education Physical Activity Lab" - 2 trials
Departments List
Total Rows: 1